MEGAN BROWN: Open Payments
NPI 1851956874 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 45 payments from 20 companies in 2025. Trend: 2023 $759 · 2024 $1,562 · 2025 $1,054
Food & beverage: $849Education: $205
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $155 |
| PFIZER INC. | 6 | $101 |
| Aveo Pharmaceuticals, Inc. | 4 | $93 |
| SOBI, INC | 1 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| ABBVIE INC. | 3 | $74 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| ARRAY BIOPHARMA INC | 3 | $58 |
| Incyte Corporation | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
Products named: RYBREVANT, FOTIVDA, Doptelet, KEYTRUDA, EPKINLY, IBRANCE, KISQALI, XALKORI.
Industry payments across OH — which companies pay providers there.
